HFIPS
An open and multidisciplinary research base under CAS
An open and multidisciplinary research base under CAS
Recently, a pharmaceutical research team led by Prof. LIU Qingsong at the Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, in collaboration with Tongji University, identified a natural compound, Timosaponin AIII (TAIII), that selectively eliminates CAR-T regulatory T cells.
HFIPS facilities enable scientific research to address world’s challenges.
